🇺🇸 FDA
Patent

US 7410981

Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

granted A61PA61P1/04A61P31/04

Quick answer

US patent 7410981 (Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers) held by Takeda Pharmaceutical Company Limited expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/04, A61P31/04, A61P43/00